Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang 464000, China.
Bioconjug Chem. 2022 May 18;33(5):929-937. doi: 10.1021/acs.bioconjchem.2c00140. Epub 2022 Apr 24.
Functional fluorescence (FL) nonviral gene vectors with high serum tolerance bear broad application prospects in gene delivery. Fluorination has been widely utilized as an effective strategy to enhance serum tolerance. Herein, we show the combination of fluorination and aggregation-induced emission (AIE) for the construction of a nonviral gene vector with low cytotoxicity, visual tracking ability, and high serum tolerance. Large π-conjugation triphenylamine (TPA) derivative with a characteristic D-π-A structure was modified with two polar [12]aneN heads and a long fluorocarbon tail, giving the vector molecule FluoTPA. FluoTPA features near-infrared (NIR) emission, large Stokes shift, and strong binding affinity toward nucleic acids. Liposomes consisting of FluoTPA and dioleoylphosphatidylethanolamine (DOPE) (FluoTPA/DOPE) can effectively deliver both plasmid DNAs (pDNAs) and siRNAs into cells. Impressively, FluoTPA/DOPE showed comparable transfection efficiency (TE) in the presence of serum content up to 30% with that in the serum-free condition and achieved 7.4 times higher TE than the commercial transfection agent lipofectamine 2000 at the same condition. Finally, spatiotemporal tracking of the delivery process in cells was demonstrated. The results in this work suggest that FluoTPA could be a reliable theranostic platform for the nonviral delivery of nucleic acid therapeutics in serum condition.
具有高血清耐受性的功能荧光(FL)非病毒基因载体在基因递送中具有广泛的应用前景。氟化已被广泛用作增强血清耐受性的有效策略。在此,我们展示了氟化和聚集诱导发射(AIE)的结合,用于构建具有低细胞毒性、可视化跟踪能力和高血清耐受性的非病毒基因载体。具有 D-π-A 结构特征的大π共轭三苯胺(TPA)衍生物用两个极性[12]烷 N 头和一个长氟碳尾进行修饰,得到载体分子 FluoTPA。FluoTPA 具有近红外(NIR)发射、大斯托克斯位移和与核酸的强结合亲和力。由 FluoTPA 和二油酰基磷脂酰乙醇胺(DOPE)组成的脂质体(FluoTPA/DOPE)可以有效地将质粒 DNA(pDNA)和 siRNA 递送到细胞中。令人印象深刻的是,在含有高达 30%血清含量的条件下,FluoTPA/DOPE 的转染效率(TE)与无血清条件下相当,在相同条件下,其 TE 比商业转染试剂脂质体 2000 高 7.4 倍。最后,在细胞中演示了递药过程的时空跟踪。这项工作的结果表明,FluoTPA 可以成为在血清条件下非病毒递送核酸治疗药物的可靠治疗平台。